Covid Vaccine To Be Given To All Children Aged 5-11 In England, Announces Sajid Javid

Children aged five to 11 in England will be offered a Covid vaccine, the government has announced.

It follows advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).

Sajid Javid, the health secretary, said the vaccine programme will be rolled out to include children in that age group at some point during April.

The decision follows similar moves in Scotland and Wales.

“Children without underlying health conditions are at low risk of serious illness from Covid-19 and the priority remains for the NHS to offer vaccines and boosters to adults and vulnerable young people, as well as to catch-up with other childhood immunisation programmes,” Javid said.

“The NHS will prepare to extend this non-urgent offer to all children during April so parents can, if they want, take up the offer to increase protection against potential future waves of Covid-19 as we learn to live with this virus.”

It is understood precise details of the expansion of the vaccine programme will be set out soon.

The UK medical regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), approved the Pfizer vaccine for use in children five to 11 last year.

The MHRA announced in December that a special “paediatric formulation” of the Pfizer vaccine was safe for use among that group.

They will be offered a much lower dose of the vaccine than what is offered to adults or children aged 12 and over.

Boris Johnson is due next Wednesday to announce the lifting of all domestic Covid rules in England, including the requirement to self-isolate after testing positive.

Javid’s announcement came just hours after Nicola Sturgeon confirmed that Scottish children aged five and over will be offered the vaccine.

She said: “Discussions with health boards on the best way of delivering vaccinations to five- to 11-year-olds have already begun. These will continue and we will provide further information when this approach is finalised. In the meantime, parents and carers of children aged between five and 11 need not do anything.

“This draft advice does not affect children in the five- to 11-year-old age group who have specific medical conditions which place them at greater risk from Covid-19. This group is already being vaccinated.”

Share Button

Concerns over ‘enormous’ backlog for NHS dentistry

Strict Covid protocols – which are still in place – have seen routine dental care dramatically reduced.

Share Button

Two glasses of wine enough to hit daily sugar limit

Some wines contain more sugar than a doughnut, but carry no nutritional information on their labels.

Share Button

Tracking seasonal and tidal effects on wastewater pollutants in the River Ganges

A new analysis of the River Ganges in West Bengal, India, highlights how wastewater flowing into the river impacts its water quality, and how that influence shifts with seasons and tides. Sayanti Kar of Jadavpur University and Asutosh College in Kolkata, India, and colleagues present these findings in the open-access journal PLOS Water on February 15, 2022.

Flowing through India and Bangladesh, the Ganges is the most sacred river in Hinduism. However, wastewater from nearby cities severely pollutes the river. The Ganges empties into the Bay of Bengal, in the Indian Ocean, and is therefore influenced by tides. Seasonal monsoons also affect the river.

To better understand the impact of tides and seasons on the River Ganges, Kar and colleagues conducted a comprehensive water quality analysis between 2014 and 2018. They focused specifically on a stretch of the river in West Bengal, India, located between Howrah Station — a major railway station near Kolkata — and Khardah, another city near Kolkata.

In 2014, after an extensive survey, the researchers selected five major outfalls where city wastewater flows into the Ganges. At each outfall, for the next four years, they monitored river water quality according to several different parameters, including measurements known as dissolved oxygen and biochemical oxygen demand, as well as concentrations of various heavy metals and fecal coliform level — an indicator of potential contamination by human feces.

The analysis, which included GIS mapping, showed that dissolved oxygen and biochemical oxygen demand, as well as levels of nitrate nitrogen and chloride, were significantly higher at each of the five sites prior to monsoon season than during monsoon season. Additionally, heavy metal and fecal coliform levels were strongly correlated with each other, and measurement of one could be used to predict the other. The researchers were also able to use their data to mathematically model the influence of tides on various water quality parameters at the five sites.

Overall, the analysis provides new insights into how outfall wastewater impacts water quality in this stretch of the Ganges, depending on seasonal and tidal conditions. This information could help inform new guidelines for safe usage of river water.

The authors add: “River Ganges is not only a symbol of faith and hope for millions of people but is also used for daily human usage and livestock management. A collaboration between Asutosh College, Jadavpur University, and Navajo Technical University investigated the influence of river flow, tidal dynamics, and seasons on distribution of pollutants entering the river from different discharge points (city outfalls) at selected river stretches to prepare river water usage guidelines.”

Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.

Share Button

Study highlights worldwide disparities in treatment rates for major depressive disorder

A combined analysis of results from 149 earlier studies finds that treatment rates for major depressive disorder remain low worldwide, particularly for people living in low and lower-middle income countries. Alize Ferrari of the University of Queensland, Australia, Modhurima Moitra of the University of Washington, U.S., and colleagues present these findings in the open-access journal PLOS Medicine.

In recent years, national and global initiatives have made increasing efforts to address the tremendous burden posed by major depressive disorder. However, treatment rates remain low. Analyses that combine results from studies on depression treatment from different regions can help identify opportunities for improvement. However, many such analyses do not adequately account for variations in study methods that make results from different studies difficult to compare.

To provide further clarity, Ferrari and colleagues conducted an updated analysis of 149 studies on treatment for major depressive disorder conducted in 84 countries between 2000 and 2021. Applying a statistical method known as Bayesian meta-regression analysis, they combined the studies to examine treatment rates around the world.

The findings of this meta-analysis suggest that treatment rates remain low worldwide, and it highlights disparities in treatment between countries with different resource levels. In particular, use of mental health services by people with major depressive disorder is estimated to be 33 percent in high-income countries and just eight percent in low and lower-middle income countries.

Rates of treatment considered to be minimally sufficient for treating major depressive disorder are lower, estimated at 23 percent for high-income countries and 3 percent in low and lower-middle income countries.

The authors note a lack of high-quality data on depression treatment for low and lower-middle income countries, mostly in Sub-Saharan Africa and South Asia; further research could attempt to address that gap and thereby improve the accuracy of the treatment rates reported in this study. Future research could also examine how to best improve treatment access in different regions.

Overall, the researchers say, their findings could help inform efforts by governments and policymakers to more effectively address depression treatment worldwide.

Ferrari adds, “Treatment coverage for major depressive disorder continues to be low globally, with many individuals failing to receive a level of care consistent with practice guideline recommendations. This highlights the need to reconsider the availability of appropriate care and facilitators of treatment as we respond to the large burden imposed by this disorder.”

Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.

Share Button

Human microbiome research excludes developing world, study finds

New studies emerge daily on the effect of the human microbiome on human health: colon cancer, ulcers, and cognitive conditions such as Alzheimer’s disease have been associated with the communities of microbes that live in our bodies. However, global research into the human microbiome is heavily biased in favor of wealthy countries such as the United States and United Kingdom, according to a study publishing February 15th in the open-access journal PLOS Biology by Richard Abdill, Elizabeth Adamowicz and Ran Blekhman at the University of Minnesota.

The authors evaluated global repositories of DNA sequencing data used to measure microbiome content and found that almost half of all publicly available samples come from subjects in the U.S., even though that country represents only 4.3 percent of the global population. These findings raise questions about whether advances in the field will be applicable to countries that have fewer resources and populations that don’t receive as much attention in the literature.

The “human microbiome” refers to the communities of microorganisms living on and in the human body — estimates suggest a person’s human cells are greatly outnumbered by the trillions of bacteria making up their microbiome, living everywhere from the small intestine to the surface of the eyeball.

Research shows that these microbes have extensive interactions with their human hosts and have wide-ranging effects, both positive and negative. Some gut microbes, for example, help break down food into nutrients that humans cannot naturally access, while others have been linked to conditions such as inflammatory bowel disease, stomach cancer, and diabetes. Accordingly, billions of dollars have been invested in researching these relationships since the early 2000s. To understand where this funding was being used, the Minnesota researchers inventoried more than 440,000 samples of human microbiome data shared in international repositories maintained by organizations such as the National Institutes of Health in the United States and Japan’s National Institute of Genetics.

“Interest in the human microbiome has been growing worldwide,” said Richard Abdill, the study’s lead author. “When we look at how the field is developing, who is being included, and where resources have been allocated, it is clear that our understanding of the ‘human’ microbiome does not include most humans. Our study is a step towards quantifying this disparity.”

There are many reasons for these disparities, such as economic and political factors that impact scientific research, and logistical difficulties with performing research in countries with less infrastructure. However, the microbiome is in turn influenced by factors such as genetics, geography, diet, and lifestyle, making it important to study many populations to find links to human health. Because of this, the authors maintain that the exclusion of the developing world from microbiome research threatens to create a situation in which future microbiome-based medical treatments may only be effective for people in some countries or populations.

Of the samples for which a country of origin could be determined, the researchers found more than 71 percent came from Europe and North America, almost five times as many as would be expected given their population. Central and Southern Asia was the most underrepresented region: Though more than 2 billion people live in countries such as India, Pakistan, and Bangladesh, only 13,620 microbiome samples were available from that region, or 1.5 percent of samples from almost 26 percent of the world’s population. No samples at all were found from countries such as Algeria, Yemen, Afghanistan, and Kazakhstan.

Blekhman adds, “Interest in the human microbiome has been growing quickly, but there are conspicuous gaps in where that interest is being directed. Our study investigated all publicly available human microbiome samples — almost half a million samples — to quantify these gaps. We found that our understanding of the ‘human’ microbiome leaves out a lot of the humans.”

Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.

Share Button

Covid in Wales: All five to 11-year-olds offered jabs

Wales becomes the first UK nation to announce it will vaccinate the younger age group.

Share Button

Vaccinated less likely to develop long Covid

As well as stopping some infections, jabs “cut the risk” of long Covid in those who still catch the virus.

Share Button

Masks ‘aggravated’ fatal dosage miscommunication at Watford Hospital

A man was given more than three times the intended dose of a drug after instructions were misheard.

Share Button

Pharmaceuticals in rivers threaten world health – study

Paracetamol, nicotine, caffeine and epilepsy and diabetes drugs were widely detected, research finds.

Share Button